ArriVent BioPharma Reports First Quarter 2024 Financial Results

Go back to ArriVent BioPharma Reports First Quarter 2024 Financial Results
(NASDAQ: AVBP) Delayed: 29.51 -0.49 (1.63%)
Previous Close $30.00    52 Week High
Open $29.99    52 Week Low
Day High $30.07    P/E N/A 
Day Low $29.13    EPS
Volume 438,999